Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Robin Yates Dulman, MD

LICENSE # 0101247856
  rdulman@psvcare.org
http://PSVCare.org

Issue Date: 6/29/2010
Expiration Date: 5/31/2026
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 5/29/2024
New York University School Of Medicine - New York NY
Rank: Instructor
Years: 2008-2010

Virginia Commonwealth University School Of Medicine-INOVA Campus - Falls Church VA
Rank: Assistant Professor
Years: 2014-2022

University Of Virginia School Of Medicine - Charlottesville VA
Rank: Assistant Professor
Years: 2022-

Academic Appointments - Non-US
Last Updated 5/29/2024
None Reported
Publications
(up to ten in the last five years)
Last Updated 5/29/2024
Splenic Infarction Due to Concomitant Hereditary Spherocytosis and Sickle Cell Trait
Journal of Pediatric Sugery
Volume: 42
Date: 12 2007
www.jpedsurg.org/article/S0022-3468%2807%2900614-8/abstract

Wild type N-ras displays anti-malignant properties, in part by downregulating decorin
J Cell Physiology
Volume: 227
Date: 06 2012

Lung Opacification
JAMA
Volume: 311
Date: 06 2014

Is Folic Acid Supplementation is Necessary in Patients with Sickle Cell Disease
Journal of Pediatric Hematology and Oncology
Volume: 39
Date: 08 2017

A Randomized Trial of the Effectiveness of the Neutropenic Diet versus Food Safety Guidelines on Infection Rate in Pediatric Oncology Patients.
Pediatric Blood and Cancer
Volume: 65
Date: 01 2018

Prospective longitudinal follow-up of children with sickle cell disease treated with hydroxyurea since infancy.
Pediatric Blood and Cancer
Volume: 66
Date: 09 2019

Robust immune responses to SARS-CoV-2 in a pediatric patient with B-Cell ALL receiving tisagenlecleucel
Pediatr Hematol Oncol .
Volume: Feb 9
Date: 02 2022
https://pubmed.ncbi.nlm.nih.gov/35135442/

Ten-year longitudinal analysis of hydroxurea implementation in a pediatric sickle cell program
Eruopean Journal of haematology
Volume: 109
Date: 11 2022

Effect of voxelotor on cardiopulmonary testing in youths with sickle cell anemia in a pilot study
pediatric blood and cancer
Volume: 70
Date: 08 2023

High hydroxyurea usage in sickle cell anemia regardless of patient demographics
pediatric blood and cancer
Volume: 71
Date: 02 2024